Remove 2020 Remove Illness Remove IT Remove Patient-Centered
article thumbnail

The Future Of Vision And Eye Care

The Medical Futurist

billion people were living with vision loss in 2020, and it is forecasted to reach 1.7 Treating less serious ailments gets faster, more targeted and more efficient, while the means for curing more serious and life-altering illnesses improve. How far can you see and hear? What about the smell of the flowers? Globally 1.1

Diabetes 105
article thumbnail

A New Normal? Assessing Trends and Changes in Inpatient General Medicine During The CO VID-19 Era [Big data]

Annals of Family Medicine

Context: The COVID pandemic disrupted global healthcare, impacting academic medical centers (AMCs) in the United States, necessitating a comprehensive understanding of its effects on healthcare delivery and utilization. Study Design: This retrospective case series analysis utilizes Vizient’s clinical database data.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Agitation Podcast Series Episode 5: Management of the child with mental health problems who is boarded in the ED

PEMBlog

This episode is a co-production of the Emergency Medical Services for Children Innovation and Improvement Center whose mission is to minimize morbidity and mortality of acutely ill and injured children across the emergency continuum. Pediatrics October 2020; 146 (4): e20201174. McEnany, Olutosin Ojugbele, Julie R. 10.1542/peds.2020-1174

article thumbnail

Using technology to reclaim our time

Today's Hospitalist

Since the mid-1990s, our capacity for innovation has never stopped as hospitalists navigate a complex landscape of acute illnesses, interprofessional collaborations and the imperative to provide efficient, high-quality care. We have seen explosive growth and become a cornerstone of modern health care systems.

article thumbnail

Deprescribing Super Special Part II: Podcast with Elizabeth Bayliss, Ariel Green, and Kevin McConeghy

GeriPal

My take home from this is that while the most preferred explanation for deprescribing statins and sedative-hypnotics is one focused on the risk of side effects, we also need to individualize it to the patient and the medication that they are taking. Welcome, Ariel. Ariel: Thanks. I’m excited to be here. Kevin: Thank you. Another in JAG.

article thumbnail

Episode 120: Antiracism in Medicine Series Episode 1 – Racism, Police Violence, and Health

The Clinical Problem Solvers

Her definition centers the idea that Black individuals did not inherit the diseases they disparately suffer from, but they inherited a disadvantaged system that creates the stark health disparities we see today. This starts with self-education and a commitment to speak up when blatant examples of racism come up in the work space and beyond.

article thumbnail

A Question 30 Years in the Making: Would a Final LDT Rule Withstand Judicial Scrutiny?

FDA Law

The PR takes on two specific statutory grounds raised by the June 22, 2020 HHS memo —the requirements for “interstate commercial” and “commercial distribution”—and argues that they are not impediments to FDA jurisdiction over LDTs. Premarket Approval or De Novo pathways).